Effects of Italian Mediterranean organic diet vs. low-protein diet in nephropathic patients according to MTHFR genotypes

Journal of Nephrology

Volumn 27, Issue 5, 2014, Pages 529-536

  Di Daniele, Nicola ^a   Di Renzo, Laura ^a,b   Noce, Annalisa ^a   Iacopino, Leonardo ^a   Ferraro, Pietro Manuel ^c   Rizzo, Mariagiovanna ^a   Sarlo, Francesca ^a   Domino, Emidio ^a   De Lorenzo, Antonino ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b National Istitute for Mediterranean Diet and Nutrigenomic Corso Italia   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Body composition; C677T MTHFR polymorphism; Cardiovascular disease risk; Chronic kidney disease; Italian Mediterranean organic diet

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; CYANOCOBALAMIN; FAT; FOLIC ACID; GREEN FLUORESCENT PROTEIN; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN; PYRIDOXINE; BIOLOGICAL MARKER; MTHFR PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; DUAL ENERGY X RAY ABSORPTIOMETRY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; ITALIAN MEDITERRANEAN ORGANIC DIET; KIDNEY DISEASE; MALE; MEDITERRANEAN DIET; PATIENT ATTITUDE; PROTEIN RESTRICTION; QUESTIONNAIRE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIET THERAPY; ENZYMOLOGY; GENETICS; MIDDLE AGED; ORGANIC FOOD; PHENOTYPE; RENAL INSUFFICIENCY, CHRONIC; TIME; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; DIET, MEDITERRANEAN; DIET, PROTEIN-RESTRICTED; FOOD, ORGANIC; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84920394927     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-014-0067-y     Document Type: Article

References (57)

1. Foley RN, Parfrey PS, Samak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(5 Suppl 3):S112
2. Pastore A, De Angelis S, Casciani S et al (2006) Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with Known MTHFR Genotypes. Clin Chem 52(1):145–148
3. Busch M, Franke S, Muller A et al (2004) Potential cardiovascular risk factors in chronic kidney disease: AGEs, Total homocysteine and metabolites, and the C-reactive protein. Kidney Int 66:338–347
4. Zhang X, Li H, Jin H, Ebin Z, Brodsky S et al (2000) Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 279(4):F671–F678
5. Zou T, Yang W, Hou Z, Yang J (2010) Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox. Acta Biochim Biophys Sin (Shanghai) 42(12):908–915. doi:10.1093/abbs/gmq102. Epub 2010 Nov 10
6. Malinowska J, Olas B (2011) Analysis of biological properties of selected elements of haemostasis after treatment with the oxidized form of homocysteine in vitro. Platelets 22(8):629–632. doi:10.3109/09537104.2011.579204. Epub 2011 May 31
7. Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylentetrahydrofolatereductase. Nat Genet 10:111–113
8. Rady PL, Szucs S, Grady J et al (2002) Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 107(2):162–168
9. Winkelmayer WC, Huber A, Wagner OF et al (2005) Associations between MTHFR 1793 G>A and plasma total homocysteine, folate, and vitamin B12 in kidney transplant recipients. Kidney Int 67:1980–1985
10. Chrysohoou C, Panagiotakos DB, Pitsavos C et al (2004) Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA study. J Am Coll Cardiol 44:152–158
11. Knoops KT, de Groot LC, Kromhout D et al (2004) Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292:1433–1439
12. Esposito K, Marfella R, Ciotola M et al (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292:1440–1446
13. Di Renzo L, Di Pierro D, Bigioni M et al (2007) Is antioxidant plasma status in humans a consequence of the antioxidant food content influence? Eur Rev Med Pharmacol Sci 11:185–192
14. K-DOQI (2004) Clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43(5 Suppl 1):S1–S290
15. World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation, WHO technical report series 894, Geneva, Switzerland
16. Parodi E, De Lorenzo A (2009) I disturbi del comportamento alimentare. Collana Universalia Enpam, vol 6
17. De Lorenzo A, Bianchi A, Maroni P et al (2013) Adiposity rather than BMI determines metabolic risk. Int J Cardiol 166(1):111–117. doi:10.1016/j.ijcard.2011.10.006
18. Cupisti A (2008) Definition of the nutritional therapy in the conservative treatment of chronic kidney disease. G Ital Nefrol 25(Suppl 42):S35–S38
19. Remer T, Manz F (1995) Potential renal acid of foods and its influence on urine pH. J Am Diet Assoc 95:791–797
20. Fidanza F, Alberti A, Fruttini D (2005) The Nicotera diet: the reference Italian Mediterranean diet. World Rev Nutr Diet 95:115–121
21. De Lorenzo A, Petroni ML, De Luca PP et al (2001) Use of quality control indices in moderately hypocaloric Mediterranean diet for treatment of obesity. Diabetes Nutr Metab 14(4):181–188
22. Di Renzo L, Di Pierro D, Bigioni M et al (2007) Is antioxidant plasma status in humans a consequence of the antioxidant food content influence? Eur Rev Med Pharmacol Sci 11:185–192
23. De Lorenzo A, Noce A, Bigioni M et al (2010) The effects of Italian Mediterranean organic diet (IMOD) on health status. Curr Pharm Des 16(7):814–824
24. LARN—Livelli di Assunzione di Riferimento di Nutrienti ed energia per la popolazione italiana. Revisione 2012. Documento di sintesi per il XXXV Congresso Nazionale SINU Bologna, 22–23 ottobre 2012
25. Lohman TG, Roche AF, Martorell R (1998) Anthropometric standardization reference manual. Human Kinetics, Champaign, IL, pp 3–8, 39–70
26. De Lorenzo A, Andreoli A, Candeloro N (1997) Within-subject variability in body composition using dual-energy X-ray absorptiometry. Clin Physiol 17:383–388
27. Word Health Organ Tech Rep Ser (2003) Diet, nutrition and the prevention of chronic diseases 916:1–149
28. Parodi E, De Lorenzo A. Diet, nutrition and prevention of chronic diseases. Geneva: WHO Technical Report Series; 2003. no. 916. www.enpam.it
29. Florkowski CM, Chew-Harris JS (2011) Methods of estimating GFR—different equations including CKD-EPI. Clin Biochem Rev 32(2):75–79
30. Dedoussis GV, Panagiotakos DB, Chrysohoou C et al (2004) Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C→T mutation on homocysteine concentrations in healthy adults: the ATTICA Study. Am J Clin Nutr 80(4):849–854
31. Sofi F, Abbate R, Gensini GF, Casini A (2010) Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 92(5):1189–1196. Epub 2010 Sep 1. Review
32. De Lorenzo A, Andreoli A, Sorge RP et al (1999) Modification of dietary habits (Mediterranean diet) and cancer mortality in a southern Italian village from 1960 to 1996. Ann NY Acad Sci 889:224–229
33. Kastorini CM, Milionis HJ, Esposito K et al (2011) The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 57(11):1299–1313
34. Esposito K, Di Palo C, Maiorino MI et al (2010) Long-term effect of mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight men. Cardiol Res Pract 20(2011):293916. doi:10.4061/2011/293916
35. Friso S, Choi SW, Girelli D et al (2001) A common mutation in the 5,10 methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99:5606–5611
36. Guinotte C, Burns M, Axume J et al (2003) Methylenetetrahydrofolatereductase 677C→T variant modulates folate status response to controlled folate intakes in young women. J Nutr 133:1272–1280
37. De Bree A, Verschuren WMM, Bjorke-Monsen Al, Van Der Put NMJ, Heil SG, Trijbels FJM, Bloom HJ (2003) Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentration in general population sample. Am J Clin Nutr 77:687–693
38. Brattstrom L, Wilcken DE (2000) Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72:315–323
39. Di Renzo L, Bigioni M, Bottini FG et al (2006) Normal weight obese syndrome: role of single nucleotide polymorphism Of Il-15rα and MTHFR 677C>T genes in the relationship between body composition and resting metabolic rate. Eur Rev Med Pharmacol Sci 10(5):235–245
40. Lambrinoudaki I, Kaparos G, Papadimitriou D et al (2008) Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women. Eur J Endocrinol 159(3):233–241
41. Lewis SJ, Ebrahim S, Davey Smith G (2005) Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate. BMJ 331:1053–1056
42. Liu X, Zhao LJ, Liu YJ, Xiong DH, Recker RR, Deng HW (2008) The MTHFR gene polymorphism is associated with lean body mass but not fat body mass. Hum Genet 123(2):189–196 Epub 2008 Jan 8
43. Gorlova OY, Amos CI, Wang NW et al (2003) Genetic linkage and imprinting effects on body mass index in children and young adults. Eur J Hum Genet 11:425–432
44. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in older people. Age Ageing 39(4):412–423. doi:10.1093/ageing/afq034. Epub 2010 Apr 13
45. Shmueli O, Horn-Saban S, Chalifa-Caspi V et al (2003) Gene Note: whole genome expression profiles in normal human tissues. C R Biol 326:1067–1072
46. Klahr S, Levey AS, Beck GJ et al (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. For the Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877–884
47. Chazot C, Kopple JD (1997) Vitamin metabolism and requirements in renal disease and renal failure. In: Kopple JD, Massry SG (eds) Nutritional management of renal disease. Williams and Wilkins, Baltimore, pp 415–478
48. Beto JA, Fada RD, Bansal VK (2004) Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines. J Am Diet Assoc 104:404–409
49. Johnson DW (2006) Dietary protein restriction as a treatment for slowing chronic kidney disease progression: the case against. Nephrology 11:58–62
50. Menon V, Wang X, Greene T et al (2005) Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney Int 67(4):1539–1546
51. Chien SC, Li SY, Chen YT et al (2013) Folic acid supplementation in end-stage renal disease patients reduces total mortality rate. J Nephrol 26(6):1097–1104. doi:10.5301/jn.5000276
52. Bostom AG, Lathrop L (1997) Hyperhomocysteinemia in end-stage renal disease: prevalence etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10–20
53. Voormolen N, Noordzij M, Grootendorst DC et al (2007) Phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22:2909–2916
54. Kanbay M, Goldsmith D, Akcay A et al (2009) Phosphate—the silent stealthy cardiorenal culprit in all stages of chronic renal disease. Blood Purif 27:220–230
55. Komaba H, Fukagawa M (2009) FGF23: a key player in mineral and bone disorder in CKD. Nefrologia 29:392–396
56. Helimi JM, Hadjadj S, Aboyans V et al (2008) Microalbuminuria and urinary albumin excretion: French guidelines. Ann Biol Clin (Paris) 66:277–284
57. Lichtenstein AH, Ausman LM, Jalbert SM et al (2002) Efficacy of a therapeutic lifestyle change/step 2 diet in moderately hypercholesterolemic middle-aged and elderly female and male subjects. J Lipid Res 43:264–273